About Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome
Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome is a rare disease catalogued by Orphanet (ORPHA:686999). It is associated with the PLAAT3 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome trials.
Search ClinicalTrials.gov for "Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome" or filter by Orphanet code ORPHA:686999 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Lipodystrophy-demyelinating peripheral sensory-motor neuropathy syndrome. Updated daily.